# Semyon Dukach

> Semyon Dukach is a seed investor at One Way Ventures (Boston) backing Software and SaaS. See 52 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [One Way Ventures](https://shizune.co/investors/profile/one-way-ventures)
- Location: Boston, United States
- Total investments: 52
- Last investment: Mar 2026
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/semyondukach
- X (Twitter): https://www.twitter.com/semyondukach
- Website: http://semyon.com
- Facebook: http://www.facebook.com/semyon.dukach

Semyon Dukach is a seed investor at One Way Ventures in Boston focused on Software and SaaS. Semyon Dukach is the Founding Partner of One Way Ventures. He previously worked at SharpSpring as a Board Chairman. Semyon Dukach attended Massachusetts Institute of Technology.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $45k–$5M |
| Angel | $278k–$705k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 10 | 19% |
| SaaS | 9 | 17% |
| Education | 7 | 13% |
| Health Care | 7 | 13% |
| Mobile | 6 | 12% |

126 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 28 | 54% |
| Angel | 8 | 15% |
| Funding Round | 5 | 10% |
| Pre-Seed | 3 | 6% |
| Convertible Note | 3 | 6% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 40 | 77% |
| Ukraine | 2 | 4% |
| Canada | 1 | 2% |
| United Kingdom | 1 | 2% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ImmuneBridge | ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematologicalcancers. They will then attack solid tumors using the special benefits of their cellular source. | $7.7M | Seed | Mar 23, 2026 |  |
| Provision | Provision is automating construction with AI. | $7M | Seed | Oct 15, 2025 |  |
| Machinery Partner | Machinery Partner helps buyers and sellers of heavy equipment to grow faster and easier with the technology and industry expertise to match their needs. | $8M | Series A | Dec 05, 2023 |  |
| Onyx Private | Onyx Private is a modern and more accessible private bank for the new generation of young professionals, investors, and entrepreneurs. We offer a premium and digital banking experience with a white-glove concierge service for all your personal finance, wealth and lifestyle needs. | $4.1M | Seed | May 22, 2023 |  |
| Impilo | Impilo is a developer of digital health operating systems aimed at improving the infrastructure underlying remote healthcare. Through its full-stack middleware technology, the company's systems provide an e-commerce and application programming interface for handling purchases, logistics, and configuration, allowing hospitals and healthcareorganizations to manage their digital health remote patient monitoring devices and supplies. | $4.5M | Seed | Feb 08, 2023 |  |
| Onyx Private | Onyx Private is a modern and more accessible private bank for the new generation of young professionals, investors, and entrepreneurs. We offer a premium and digital banking experience with a white-glove concierge service for all your personal finance, wealth and lifestyle needs. | $500K | Seed | May 02, 2022 |  |
| Machinery Partner | Machinery Partner helps buyers and sellers of heavy equipment to grow faster and easier with the technology and industry expertise to match their needs. | $4.5M | Seed | Aug 12, 2021 |  |
| Influ2 | Influ2 is the first person-based marketing platform, pioneering a new approach to account-based marketing. The solution empowers B2B marketers to target chosen decision-makers, capture their intent, and track engagement at the individual level. The company has 75+ enterprise and medium-sized clients globally, including Fortune 500 B2B enterprisessuch as NVIDIA, Capgemini, and Episerver. Influ2 runs offices in NY and CA, with 50+ employees on board. With Influ2, every user’s engagement is identified. Having this information helps B2B marketers develop more thoughtful and engaging campaigns that result in a 4-7x increase in leads. Influ2 platform allows users to build an audience, upload personalized messages & visuals, and monitor all the interactions on both account and individual levels The behavioral scoring model identifies leads before they submit a lead form. Influ2 includes a person tracker, so marketers can see everyone who has interacted with their campaign by name, company, and other related data. The solution is compatible with Salesforce, HubSpot, Marketo, Creatio, Outreach, ActiveCampaign, and many other CRM and marketing automation platforms. | $3.4M | Seed | Sep 24, 2020 |  |
| Humanity | Humanity is a healthcare company that aims to extend the healthspan of humanity. It develops a software application designed to provide information on how to stop the aging process. The company's service allows people to try different interventions and solutions to help move those biomarkers in a positive direction and thus reduce, and in somecases, stop the loss of function and thus the aging damage.Founded in 2019 by Peter Ward and Michael Geer, Humanity is headquartered in Boston, Massachusetts. | $2.5M | Seed | Aug 20, 2020 |  |
| BRIO Systems | BRIO Systems offers a complete COVID-19 testing system to help employers keep teams safe and businesses on track.The turnkey solution for COVID-19 screening that urgently addresses the needs of employers and providers of critical/essential infrastructure. It bundles laboratory testing, dropship fulfillment of collection kits, testrequisitioning, medical supervision, and digital reporting in a single product, working with a network of FDA-certified laboratories to support up to 50, 000 tests daily. BRIO is working with leading companies across a variety of verticals, helping them protect their workforce and make data-driven risk-mitigation decisions.In 2017, Boris Lipchin and Thos Niles established the company in Boston, Massachusetts. | $1.9M | Seed | Aug 05, 2020 |  |

10 of 52 investments shown.

## Co-investors
- [Bantam Group](https://shizune.co/investors/profile/bantam-group) — VC Fund, 7 deals together
- [Techstars](https://shizune.co/investors/profile/techstars) — VC Fund, 7 deals together
- [Techstars Boston Accelerator](https://shizune.co/investors/profile/techstars-boston-accelerator) — VC Fund, 5 deals together
- [Village Global](https://shizune.co/investors/profile/village-global-2) — VC Fund, 4 deals together
- [186 Ventures](https://shizune.co/investors/profile/186-ventures) — VC Fund, 3 deals together
- [Techstars Ventures](https://shizune.co/investors/profile/bullet-time-ventures) — VC Fund, 3 deals together

## About One Way Ventures

VC Fund · Boston, United States

One Way Ventures is a seed-stage fund that invests in immigrant tech founders.

5 contacts available at One Way Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Semyon Dukach | Founding Partner | https://shizune.co/investors/profile/semyon-dukach |
| Alissa Carroll | Investment Analyst | https://shizune.co/investors/profile/alissa-carroll |
| Eugene Malobrodsky | General Partner | https://shizune.co/investors/profile/eugene-malobrodsky |
| Joe Zhou | Limited Partner | https://shizune.co/investors/profile/chuhao-zhou |
| Lex Zhao | Partner | https://shizune.co/investors/profile/lex-zhao |

## Similar investors

### Similar industry
- [Great Oaks Venture Capital](https://shizune.co/investors/profile/great-oaks-venture-capital) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Ukrainian Startup Fund](https://shizune.co/investors/profile/ukrainian-startup-fund) — VC Fund
- [SMRK VC Fund](https://shizune.co/investors/profile/smrk-vc-fund) — VC Fund
- [European Bank for Reconstruction and Development](https://shizune.co/investors/profile/european-bank-for-reconstruction-and-development-ebrd) — VC Fund

## Featured in investor lists
- [EdTech Angel Investors](https://shizune.co/investors/edtech-angel-investors)
- [EdTech Angel Investors in United States](https://shizune.co/investors/edtech-angel-investors-united-states)
- [Mobile Apps Angel Investors in United States](https://shizune.co/investors/mobile-apps-angel-investors-united-states)
- [All Investors in Ukraine](https://shizune.co/investors/investors-ukraine)
- [All Angel Investors in Ukraine](https://shizune.co/investors/angel-investors-ukraine)
- [Social Angel Investors](https://shizune.co/investors/social-angel-investors)

## FAQ

### What does Semyon Dukach invest in?

Semyon Dukach invests primarily in Software, SaaS and Education startups, most often at Seed and Angel stage. Most of the 52 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Semyon Dukach's check size?

Semyon Dukach typically joins rounds of $45k–$5M at Seed and $278k–$705k at Angel. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Semyon Dukach participates in.

### When did Semyon Dukach last invest?

The most recent investment recorded for Semyon Dukach closed in Mar 2026. Shizune tracks 52 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co